ALK and ovarian cancer: This body of research not only underscores the pivotal role of SOX3 in ovarian cancer but also connects it with other key molecular players like ALK, offering a better understanding of the molecular underpinnings of ovarian cancer and highlighting potential targets for therapeutic intervention.